Roles of autophagy induced by natural compounds in prostate cancer

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Naponelli, V ^a,b   Modernelli, A ^a   Bettuzzi, S ^a,b   Rizzi, F ^a,b  

^a UNIVERSITY OF PARMA   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; CHOLESTIN; ISOTHIOCYANIC ACID DERIVATIVE; MENADIONE; NATURAL PRODUCT; PIPERINE; PIPERLONGUMINE; POLYPHENOL DERIVATIVE; ROTTLERIN; UNCLASSIFIED DRUG; URSOLIC ACID;

AUTOPHAGY; CELL FATE; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; DNA FRAGMENTATION; DRUG MECHANISM; ENZYME ACTIVITY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MALE; NATURAL PRODUCT INDUCED AUTOPHAGY; NONHUMAN; PROSTATE CANCER; PROTEIN FUNCTION; REVIEW; TUMOR MICROENVIRONMENT; CARCINOGENESIS; GENETICS; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROSTATIC NEOPLASMS;

AUTOPHAGY; CARCINOGENESIS; HUMANS; MALE; MOLECULAR TARGETED THERAPY; PROSTATIC NEOPLASMS;

EID: 84925337181     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/121826     Document Type: Review

References (160)

1. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent et al., "Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012," European Journal of Cancer, vol. 49, no. 6, pp. 1374-1403, 2013.
2. A. J. Meijer and P. Codogno, "Regulation and role of autophagy in mammalian cells," International Journal of Biochemistry and Cell Biology, vol. 36, no. 12, pp. 2445-2462, 2004.
3. G. Mariño, M. Niso-Santano, E.H. Baehrecke, and G. Kroemer, "Self-consumption: the interplay of autophagy and apoptosis," Nature Reviews Molecular Cell Biology, vol. 15, no. 2, pp. 81-94, 2014.
4. B. Levine and G. Kroemer, "Autophagy in the pathogenesis of disease," Cell, vol. 132, no. 1, pp. 27-42, 2008.
5. N. Mizushima, T. Yoshimori, and Y. Ohsumi, "The role of atg proteins in autophagosome formation," Annual Review of Cell and Developmental Biology, vol. 27, pp. 107-132, 2011.
6. E. Itakura and N. Mizushima, "Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins," Autophagy, vol. 6, no. 6, pp. 764-776, 2010.
7. J. L. Webber and S. A. Tooze, "New insights into the function of Atg9," FEBS Letters, vol. 584, no. 7, pp. 1319-1326, 2010.
8. R. C. Russell, H. X. Yuan, and K. L. Guan, "Autophagy regulation by nutrient signaling," Cell Research, vol. 24, no. 1, pp. 42-57, 2014.
9. L. L. Fu, Y. Cheng, and B. Liu, "Beclin-1: autophagic regulator and therapeutic target in cancer," International Journal of Biochemistry and Cell Biology, vol. 45, no. 5, pp. 921-924, 2013.
10. R. Kang, H. J. Zeh, M. T. Lotze, and D. Tang, "The Beclin 1 network regulates autophagy and apoptosis," Cell Death and Differentiation, vol. 18, no. 4, pp. 571-580, 2011.
11. E. Zalckvar, H. Berissi, M. Eisenstein, and A. Kimchi, "Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL," Autophagy, vol. 5, no. 5, pp. 720-722, 2009.
12. R. C. Wang, Y. Wei, Z. An et al., "Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation," Science, vol. 338, no. 6109, pp. 956-959, 2012.
13. Y. Wei, S. Pattingre, S. Sinha, M. Bassik, and B. Levine, "JNK1-mediated phosphorylation of Bcl-2 regulates starvationinduced autophagy," Molecular Cell, vol. 30, no. 6, pp. 678-688, 2008.
14. H. Jiang, D. Cheng, W. Liu, J. Peng, and J. Feng, "Protein kinase C inhibits autophagy and phosphorylates LC3," Biochemical and Biophysical Research Communications, vol. 395, no. 4, pp. 471-476, 2010.
15. S. J. Cherra III, S. M. Kulich, G. Uechi et al., "Regulation of the autophagy protein LC3 by phosphorylation," The Journal of Cell Biology, vol. 190, no. 4, pp. 533-539, 2010.
16. E. White and R. S. DiPaola, "The double-edged sword of autophagy modulation in cancer," Clinical Cancer Research, vol. 15, no. 17, pp. 5308-5316, 2009.
17. T. Shintani and D. J. Klionsky, "Autophagy in health and disease: a double-edged sword," Science, vol. 306, no. 5698, pp. 990-995, 2004.
18. F. Lozy and V. Karantza, "Autophagy and cancer cell metabolism," Seminars in Cell and Developmental Biology, vol. 23, no. 4, pp. 395-401, 2012.
19. K. Degenhardt, R. Mathew, B. Beaudoin et al., "Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis," Cancer Cell, vol. 10, no. 1, pp. 51-64, 2006.
20. V. Karantza-Wadsworth, S. Patel, O. Kravchuk et al., "Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis," Genes and Development, vol. 21, no. 13, pp. 1621-1635, 2007.
21. K. N. Dalby, I. Tekedereli, G. Lopez-Berestein, and B. Ozpolat, "Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer," Autophagy, vol. 6, no. 3, pp. 322-329, 2010.
22. P. Maycotte and A. Thorburn, "Autophagy and cancer therapy," Cancer Biology and Therapy, vol. 11, no. 2, pp. 127-137, 2011.
23. P. Boya, R. A. González-Polo, N. Casares et al., "Inhibition of macroautophagy triggers apoptosis," Molecular and Cellular Biology, vol. 25, no. 3, pp. 1025-1040, 2005.
24. X. Qu, J. Yu, G. Bhagat et al., "Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene," The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1809-1820, 2003.
25. V. M. Aita, X. H. Liang, V. V. V. S. Murty et al., "Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21," Genomics, vol. 59, no. 1, pp. 59-65, 1999.
26. Z. Yue, S. Jin, C. Yang, A. J. Levine, and N. Heintz, "Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 15077-15082, 2003.
27. Y. Takahashi, T. Hori, T. K. Cooper et al., "Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Mycdriven lymphomagenesis via suppression of mitophagy," Blood, vol. 121, no. 9, pp. 1622-1632, 2013.
28. R. Mathew, C. M. Karp, B. Beaudoin et al., "Autophagy suppresses tumorigenesis through elimination of p62," Cell, vol. 137, no. 6, pp. 1062-1075, 2009.
29. G. Mariño, N. Salvador-Montoliu, A. Fueyo, E. Knecht, N. Mizushima, and C. López-Otín, "Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3," The Journal of Biological Chemistry, vol. 282, no. 25, pp. 18573-18583, 2007.
30. Z. Zhao, S. Oh, D. Li et al., "A dual role for UVRAG in maintaining chromosomal stability independent of autophagy," Developmental Cell, vol. 22, no. 5, pp. 1001-1016, 2012.
31. A. Eisenberg-Lerner and A. Kimchi, "The paradox of autophagy and its implication in cancer etiology and therapy," Apoptosis, vol. 14, no. 4, pp. 376-391, 2009.
32. M. T. Rosenfeldt, J. O'Prey, J. P. Morton et al., "P53 status determines the role of autophagy in pancreatic tumour development," Nature, vol. 504, no. 7479, pp. 296-300, 2013.
33. R. Mathew, V. Karantza-Wadsworth, and E. White, "Role of autophagy in cancer," Nature Reviews Cancer, vol. 7, no. 12, pp. 961-967, 2007.
34. S. Phin, M. W. Moore, and P. D. Cotter, "Genomic rearrangements of PTEN in prostate cancer," Frontiers in Oncology, vol. 3, p. 240, 2013.
35. X. Gao, A. Zacharek, A. Salkowski et al., "Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer," Cancer Research, vol. 55, no. 5, pp. 1002-1005, 1995.
36. J. P. Elo, P. Härkönen, A. P. Kyllönen et al., "Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer," Cancer Research, vol. 57, no. 16, pp. 3356-3359, 1997.
37. C. Liu, P. Xu, D. Chen et al., "Roles of autophagy-related genes Beclin-1 and LC3 in the development and progression of prostate cancer and benign prostatic hyperplasia," Biomedical Reports, vol. 1, no. 6, pp. 855-860, 2013.
38. A. Giatromanolaki, E. Sivridis, S. Mendrinos, A. V. Koutsopoulos, and M. I. Koukourakis, "Autophagy proteins in prostate cancer: relation with anaerobic metabolism and Gleason score," Urologic Oncology: Seminars and Original Investigations, vol. 32, no. 1, pp. 39.e11-39.e18, 2014.
39. A. Herman-Antosiewicz, D. E. Johnson, and S. V. Singh, "Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells," Cancer Research, vol. 66, no. 11, pp. 5828-5835, 2006.
40. A. R. Vyas, E.-R. Hahm, J. A. Arlotti et al., "Chemoprevention of prostate cancer by d, l-sulforaphane is augmented by pharmacological inhibition of autophagy," Cancer Research, vol. 73, no. 19, pp. 5985-5995, 2013.
41. D. Xiao, A. A. Powolny, J. Antosiewicz et al., "Cellular responses to cancer chemopreventive agent D, L-sulforaphane in human prostate cancer cells are initiated by mitochondrial reactive oxygen species," Pharmaceutical Research, vol. 26, no. 7, pp. 1729-1738, 2009.
42. J. F. Lin, T. F. Tsai, P. C. Liao et al., "Benzyl isothiocyanate induces protective autophagy in human prostate cancer cells via inhibition ofmTOR signaling," Carcinogenesis, vol. 34, no. 2, pp. 406-414, 2013.
43. D. Xiao, A. A. Powolny, M. B. Moura et al., "Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells," Journal of Biological Chemistry, vol. 285, no. 34, pp. 26558-26569, 2010.
44. A. Bommareddy, E.-R. Hahm, D. Xiao et al., "Atg5 regulates Phenethyl isothiocyanate-lnduced autophagic and apoptotic cell death in human prostate cancer cells," Cancer Research, vol. 69, no. 8, pp. 3704-3712, 2009.
45. A. A. Powolny, A. Bommareddy, E.-R. Hahm et al., "Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer," Journal of the National Cancer Institute, vol. 103, no. 7, pp. 571-584, 2011.
46. G. Li, P. Rivas, R. Bedolla et al., "Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: Involvement of SIRT1/S6K axis," Cancer Prevention Research, vol. 6, no. 1, pp. 27-39, 2013.
47. F. Rizzi, V. Naponelli, A. Silva et al., "Polyphenon E, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis," Carcinogenesis, vol. 35, no. 4, pp. 828-839, 2014.
48. M.-H. Teiten, F. Gaascht, M. Cronauer, E. Henry, M. Dicato, and M. Diederich, "Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway," International Journal of Oncology, vol. 38, no. 3, pp. 603-611, 2011.
49. J. Lian, X. Wu, F. He et al., "A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum," Cell Death and Differentiation, vol. 18, no. 1, pp. 60-71, 2011.
50. J. Lian, Z. Ni, X. Dai et al., "Sorafenib sensitizes (-)-gossypolinduced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and bak activation," Molecular Cancer Therapeutics, vol. 11, no. 2, pp. 416-426, 2012.
51. X. Q. Zhang, X. F. Huang, X. B. Hu et al., "Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells in vitro," Asian Journal of Andrology, vol. 12, no. 5, pp. 697-708, 2010.
52. P. Chen, J. Yu, B. Chalmers et al., "Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy," Anti-Cancer Drugs, vol. 23, no. 4, pp. 437-444, 2012.
53. M. Tomasetti, L. Nocchi, J. Neuzil et al., "Alpha-tocopheryl succinate inhibits autophagic survival of prostate cancer cells induced by vitamin K3 and ascorbate to trigger cell death," PLoS ONE, vol. 7, no. 12, Article IDe52263, 2012.
54. D. Kumar, S. Shankar, and R. K. Srivastava, "Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway," Cancer Letters, vol. 343, no. 2, pp. 179-189, 2014.
55. D.-Y. Ouyang, L.-H. Zeng, H. Pan et al., "Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy," Food and Chemical Toxicology, vol. 60, pp. 424-430, 2013.
56. P. Makhov, K. Golovine, E. Teper et al., "Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death," British Journal of Cancer, vol. 110, no. 4, pp. 899-907, 2014.
57. S. W. Shin, S. Y. Kim, and J.-W. Park, "Autophagy inhibition enhances ursolic acid-induced apoptosis in PC3 cells," Biochimica et Biophysica Acta, vol. 1823, no. 2, pp. 451-457, 2012.
58. H. Jiang, J. Sun, Q. Xu et al., "Marchantin M: a novel inhibitor of proteasome induces autophagic cell death in prostate cancer cells," Cell Death and Disease, vol. 4, article e761, 2013.
59. R.-J. Chen, C.-M. Hung, Y.-L. Chen, M.-D. Wu, G.-F. Yuan, and Y.-J. Wang, "Monascuspiloin induces apoptosis and autophagic cell death in human prostate cancer cells via the akt and AMPK signaling pathways," Journal of Agricultural and Food Chemistry, vol. 60, no. 29, pp. 7185-7193, 2012.
60. H.-W. Chiu, W.-H. Fang, Y.-L. Chen et al., "Monascuspiloin enhances the radiation sensitivity of human prostate cancer cells by stimulating endoplasmic reticulum stress and inducing autophagy," PLoS ONE, vol. 7, no. 7, Article ID e40462, 2012.
61. B. Liu, Q. Mao, M. Cao, and L. Xie, "Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis," International Journal of Urology, vol. 19, no. 2, pp. 134-141, 2012.
62. R. Chan, K. Lok, and J. Woo, "Prostate cancer and vegetable consumption," Molecular Nutrition and Food Research, vol. 53, no. 2, pp. 201-216, 2009.
63. S.V. Singh and K. Singh, "Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research," Carcinogenesis, vol. 33, no. 10, pp. 1833-1842, 2012.
64. J. D. Clarke, R. H. Dashwood, and E. Ho, "Multi-targeted prevention of cancer by sulforaphane," Cancer Letters, vol. 269, no. 2, pp. 291-304, 2008.
65. J. D. Brooks and V. Paton, "Potent induction of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agent," Prostate Cancer and Prostatic Diseases, vol. 2, supplement 3, p. S8, 1999.
66. J. D. Clarke, A. Hsu, Z. Yu, R. H. Dashwood, and E. Ho, "Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells," Molecular Nutrition and Food Research, vol. 55, no. 7, pp. 999-1009, 2011.
67. S. V. Singh, R. Warin, D. Xiao et al., "Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells," Cancer Research, vol. 69, no. 5, pp. 2117-2125, 2009.
68. A. Basu and S. Haldar, "Dietary isothiocyanate mediated apoptosis of human cancer cells is associated with Bcl-xL phosphorylation," International Journal of Oncology, vol. 33, no. 4, pp. 657-663, 2008.
69. S. K. Srivastava, D. Xiao, K. L. Lew et al., "Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenograft in vivo," Carcinogenesis, vol. 24, no. 10, pp. 1665-1670, 2003.
70. D. Xiao, S. K. Srivastava, K. L. Lew et al., "Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis," Carcinogenesis, vol. 24, no. 5, pp. 891-897, 2003.
71. D. Xiao, A. Bommareddy, S.-H. Kim, A. Sehrawat, E.-R. Hahm, and S. V. Singh, "Benzyl isothiocyanate causes FoxO1-mediated autophagic death in human breast cancer cells," PLoS ONE, vol. 7, no. 3, Article IDe32597, 2012.
72. T. Nishikawa, N. H. Tsuno, Y. Okaji et al., "Inhibition of autophagy potentiates sulforaphane-induced apoptosis in human colon cancer cells," Annals of Surgical Oncology, vol. 17, no. 2, pp. 592-602, 2010.
73. S. Kanematsu, N. Uehara, H. Miki et al., "Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells," Anticancer Research, vol. 30, no. 9, pp. 3381-3390, 2010.
74. P. Naumann, F. Fortunato, H. Zentgraf, M. W. Büchler, I. Herr, and J. Werner, "Autophagy and cell death signaling following dietary sulforaphane act independently of each other and require oxidative stress in pancreatic cancer," International Journal of Oncology, vol. 39, no. 1, pp. 101-109, 2011.
75. 2/Mphase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C," The Journal of Biological Chemistry, vol. 279, no. 24, pp. 25813-25822, 2004.
76. S. Choi, K. L. Lew, H. Xiao et al., "D, L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1," Carcinogenesis, vol. 28, no. 1, pp. 151-162, 2007.
77. S. Choi and S. V. Singh, "Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent," Cancer Research, vol. 65, no. 5, pp. 2035-2043, 2005.
78. A. V. Singh, D. Xiao, K. L. Lew, R. Dhir, and S. V. Singh, "Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth PC-3 xenografts in vivo," Carcinogenesis, vol. 25, no. 1, pp. 83-90, 2004.
79. M. C. Myzak, P. Tong, W.-M. Dashwood, R. H. Dashwood, and E. Ho, "Sulforaphane retards the growth of human PC- 3 xenografts and inhibits HDAC activity in human subjects," Experimental Biology and Medicine, vol. 232, no. 2, pp. 227-234, 2007.
80. S. V. Singh, S. K. Srivastava, S. Choi et al., "Sulforaphaneinduced cell death in human prostate cancer cells is initiated by reactive oxygen species," Journal of Biological Chemistry, vol. 280, no. 20, pp. 19911-19924, 2005.
81. K. C. Liu, Y. A. T. Huang, P. P. Wu et al., "The roles of AIF and Endo G in the apoptotic effects of benzyl isothiocyanate on DU 145 human prostate cancer cells via themitochondrial signaling pathway," International Journal of Oncology, vol. 38, no. 3, pp. 787-796, 2011.
82. D. Xiao, C. S. Jonhson, D. L. Trump, and S. V. Singh, "Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells," Molecular Cancer Therapeutics, vol. 3, no. 5, pp. 567-575, 2004.
83. D. Xiao, Y. Zeng, S. Choi, K. L. Lew, J. B. Nelson, and S. V. Singh, "Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax," Clinical Cancer Research, vol. 11, no. 7, pp. 2670-2679, 2005.
84. D. Xiao, K. L. Lew, Y. Zeng et al., "Phenethyl isothiocyanate induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of themitochondrial membrane potential," Carcinogenesis, vol. 27, no. 11, pp. 2223-2234, 2006.
85. A. Barve, T.O. Khor, X. Hao et al., "Murine prostate cancer inhibition by dietary phytochemicals-curcumin and phenyethylisothiocyanate," Pharmaceutical Research, vol. 25, no. 9, pp. 2181-2189, 2008.
86. 2/M phase arrest via p53 expression and induces apoptosis through caspase- and mitochondria dependent signaling pathways in human prostate cancerDU145 cells," Anticancer Research, vol. 31, no. 5, pp. 1691-1702, 2011.
87. C. Xue, H. A. Pasolli, I. Piscopo et al., "Mitochondrial structure alteration in human prostate cancer cells upon initial interaction with a chemopreventive agent phenethyl isothiocyanate," Cancer Cell International, vol. 14, no. 1, article 30, 2014.
88. S. Cimino, G. Sortino, V. Favilla et al., "Polyphenols: key issues involved in chemoprevention of prostate cancer," Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 632959, 8 pages, 2012.
89. A. Bommareddy, W. Eggleston, S. Prelewicz et al., "Chemoprevention of prostate cancer by major dietary phytochemicals," Anticancer Research, vol. 33, no. 10, pp. 4163-4174, 2013.
90. N. Hasima and B. Ozpolat, "Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer," Cell Death and Disease, vol. 5, no. 11, Article ID e1509, 2014.
91. M. Jang, L. Cai, G. O. Udeani et al., "Cancer chemopreventive activity of resveratrol, a natural product derived from grapes," Science, vol. 275, no. 5297, pp. 218-220, 1997.
92. L. G. Carter, J. A. D'Orazio, and K. J. Pearson, "Resveratrol and cancer: focus on in vivo evidence," Endocrine Related Cancer, vol. 21, no. 3, pp. R209-R225, 2014.
93. M. Jasiński, L. Jasińska, and M. Ogrodowczyk, "Resveratrol in prostate diseases-a short review," Central European Journal of Urology, vol. 66, no. 2, pp. 144-149, 2013.
94. C. K. Singh, M. A. Ndiaye, and N. Ahmad, "Resveratrol and cancer: challenges for clinical translation," Biochimica et Biophysica Acta-Molecular Basis of Disease, 2014.
95. M. Wang, T. Yu, C. Zhu et al., "Resveratrol triggers protective autophagy through the ceramide/Akt/mTOR pathway in melanoma B16 cells," Nutrition and Cancer, vol. 66, no. 3, pp. 435-440, 2014.
96. N. F. Trincheri, C. Follo, G. Nicotra, C. Peracchio, R. Castino, and C. Isidoro, "Resveratrol-induced apoptosis depends on the lipid kinase activity of Vps34 and on the formation of autophagolysosomes," Carcinogenesis, vol. 29, no. 2, pp. 381-389, 2008.
97. N. Khan, V. M. Adhami, and H. Mukhtar, "Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies," Nutrition and Cancer, vol. 61, no. 6, pp. 836-841, 2009.
98. J. D. Lambert, "Does tea prevent cancer? Evidence fromlaboratory and human intervention studies," The American Journal of Clinical Nutrition, vol. 98, supplement 6, pp. 1667S-1675S, 2013.
99. C. S. Yang, J. Ju, G. Lu et al., "Cancer prevention by tea and tea polyphenols," Asia Pacific Journal of Clinical Nutrition, vol. 17, supplement 1, pp. 245-248, 2008.
100. P. Davalli, F. Rizzi, A. Caporali et al., "Anticancer activity of green tea polyphenols in prostate gland," Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 984219, 18 pages, 2012.
101. J. J. Johnson, H. H. Bailey, and H. Mukhtar, "Green tea polyphenols for prostate cancer chemoprevention: a translational perspective," Phytomedicine, vol. 17, no. 1, pp. 3-13, 2010.
102. V. Venkateswaran and L. H. Klotz, "Diet and prostate cancer: mechanisms of action and implications for chemoprevention," Nature Reviews Urology, vol. 7, no. 8, pp. 442-453, 2010.
103. S. Gupta, K. Hastak, N. Ahmad, J. S. Lewin, and H. Mukhtar, "Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10350-10355, 2001.
104. C. E. Harper, B.B. Patel, J. Wang, I. A. Eltoum, and C. A. Lamartiniere, "Epigallocatechin-3-gallate suppresses early stage, but not late stage prostate cancer inTRAMP mice: mechanisms of action," Prostate, vol. 67, no. 14, pp. 1576-1589, 2007.
105. S. M. Henning, P. Wang, J. Said et al., "Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis," Journal of Nutritional Biochemistry, vol. 23, no. 11, pp. 1537-1542, 2012.
106. S. Bettuzzi, M. Brausi, F. Rizzi, G. Castagnetti, G. Peracchia, and A. Corti, "Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with highgrade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study," Cancer Research, vol. 66, no. 2, pp. 1234-1240, 2006.
107. J. McLarty, R. L. H. Bigelow, M. Smith, D. Elmajian, M. Ankem, and J. A. Cardelli, "Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro," Cancer Prevention Research, vol. 2, no. 7, pp. 673-682, 2009.
108. A. Jatoi, N. Ellison, P. A. Burch et al., "A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma," Cancer, vol. 97, no. 6, pp. 1442-1446, 2003.
109. E. Choan, R. Segal, D. Jonker et al., "Aprospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach," Urologic Oncology, vol. 23, no. 2, pp. 108-113, 2005.
110. M. M. Nguyen, F. R. Ahmann, R. B. Nagle et al., "Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities," Cancer Prevention Research, vol. 5, no. 2, pp. 290-298, 2012.
111. M. Brausi, F. Rizzi, and S. Bettuzzi, "Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update," European Urology, vol. 54, no. 2, pp. 472-473, 2008.
112. H.-S. Kim, M. J. Quon, and J.-A. Kim, "New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate," Redox Biology, vol. 2, pp. 187-195, 2014.
113. J. M. Witkin and X. Li, "Curcumin, an active constiuent of the ancient medicinal herb Curcuma longa L.: some uses and the establishment and biological basis of medical efficacy," CNS & Neurol Disord-Drug Targets, vol. 12, no. 4, pp. 487-497, 2013.
114. A. H. Rahmani, M. A. Al Zohairy, S. M. Aly, and M. A. Khan, "Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways," BioMed Research International, vol. 2014, Article ID 761608, 15 pages, 2014.
115. S. C. Gupta, S. Prasad, J. H. Kim et al., "Multitargeting by curcumin as revealed by molecular interaction studies," Natural Product Reports, vol. 28, no. 12, pp. 1937-1955, 2011.
116. K. Zikaki, I.-K. Aggeli, C. Gaitanaki, and I. Beis, "Curcumin induces the apoptotic intrinsic pathway via upregulation of reactive oxygen species and JNKs in H9c2 cardiac myoblasts," Apoptosis, vol. 19, no. 6, pp. 958-974, 2014.
117. G. O'Sullivan-Coyne, G. C. O'Sullivan, T. R. O'Donovan, K. Piwocka, and S. L. McKenna, "Curcumin induces apoptosisindependent death in oesophageal cancer cells," British Journal of Cancer, vol. 101, no. 9, pp. 1585-1595, 2009.
118. K. Wolanin, A. Magalska, G. Mosieniak et al., "Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Ablexpressing cells," Molecular Cancer Research, vol. 4, no. 7, pp. 457-469, 2006.
119. H. Aoki, Y. Takada, S. Kondo, R. Sawaya, B. B. Aggarwal, and Y. Kondo, "Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of akt and extracellular signal-regulated kinase signaling pathways," Molecular Pharmacology, vol. 72, no. 1, pp. 29-39, 2007.
120. G. Z. Zhou, S. N. Zhang, L. Zhang, G. C. Sun, and X.-B. Chen, "A synthetic curcumin derivative hydrazinobenzoylcurcumin induces autophagy in A549 lung cancer cells," Pharmaceutical Biology, vol. 52, no. 1, pp. 111-116, 2014.
121. J. Y. Kim, T. J. Cho, B. H. Woo et al., "Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells," Archives of Oral Biology, vol. 57, no. 8, pp. 1018-1025, 2012.
122. B. Li, T. Takeda, K. Tsuiji et al., "Curcumin induces crossregulation between autophagy and apoptosis in uterine leiomyosarcoma cells," International Journal of Gynecological Cancer, vol. 23, no. 5, pp. 803-808, 2013.
123. W. Zhuang, L. Long, B. Zheng et al., "Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy," Cancer Science, vol. 103, no. 4, pp. 684-690, 2012.
124. G. Mosieniak, M. Adamowicz, O. Alster et al., "Curcumin induces permanent growth arrest of human colon cancer cells: link between senescence and autophagy," Mechanisms of Ageing and Development, vol. 133, no. 6, pp. 444-455, 2012.
125. C. Kantara, M. O'Connell, S. Sarkar, S. Moya, R. Ullrich, and P. Singh, "Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1-siRNA," Cancer Research, vol. 74, no. 9, pp. 2487-2498, 2014.
126. S. Patschan, J. Chen, A. Polotskaia et al., "Lipid mediators of autophagy in stress-induced premature senescence of endothelial cells," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 294, no. 3, pp. H1119-H1129, 2008.
127. L. Yu and S. Liu, "Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics," Seminars in Cancer Biology, vol. 23, no. 6, part B, pp. 553-560, 2013.
128. X. Pang, Y. Wu, B. Lu et al., "(-)-gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis," Molecular Cancer Therapeutics, vol. 10, no. 5, pp. 795-805, 2011.
129. Y. Meng, W. Tang, Y. Dai et al., "Natural BH3 mimetic (-)- gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa," Molecular Cancer Therapeutics, vol. 7, no. 7, pp. 2192-2202, 2008.
130. G. Liu, W. K. Kelly, G. Wilding, L. Leopold, K. Brill, and B. Somer, "An open-label, multicenter, phase I/II study of singleagent AT-101 in men with castrate-resistant prostate cancer," Clinical Cancer Research, vol. 15, no. 9, pp. 3172-3176, 2009.
131. G. Sonpavde, V. Matveev, J. M. Burke et al., "Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer," Annals of Oncology, vol. 23, no. 7, Article ID mdr555, pp. 1803-1808, 2012.
132. D.W. Lamson and S.M. Plaza, "The anticancer effects of vitamin K," Alternative Medicine Review, vol. 8, no. 3, pp. 303-318, 2003.
133. J. Du, J. J. Cullen, and G. R. Buettner, "Ascorbic acid: chemistry, biology and the treatment of cancer," Biochimica et Biophysica Acta, vol. 1826, no. 2, pp. 443-457, 2012.
134. T. Yokoyama, K. Miyazawa, M. Naitoet al., "VitaminK2 induces autophagy and apoptosis simultaneously in leukemia cells," Autophagy, vol. 4, no. 5, pp. 629-640, 2008.
135. S. Ohtani, A. Iwamaru, W. Deng et al., "Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy," Cancer Research, vol. 67, no. 13, pp. 6293-6303, 2007.
136. S.-W. Hong, S.-H. Lee, J.-H. Moon et al., "SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment," Oncogene, vol. 32, no. 12, pp. 1508-1517, 2013.
137. H. Kawakita, A. Tsuchida, K. Miyazawa et al., "Growth inhibitory effects of vitamin K2 on colon cancer cell lines via different types of cell death including autophagy and apoptosis," International Journal of Molecular Medicine, vol. 23, no. 6, pp. 709-716, 2009.
138. M. Enomoto, A. Tsuchida, K. Miyazawa et al., "Vitamin K2-induced cell growth inhibition via autophagy formation in cholangiocellular carcinoma cell lines," International Journal of Molecular Medicine, vol. 20, no. 6, pp. 801-808, 2007.
139. C. Yang and L.-O. Han, "Knockdown of Beclin 1 inhibits vitamin K3-induced autophagy, but promotes apoptosis of human hepatoma SMMC-7721 cells," Molecular Medicine Reports, vol. 3, no. 5, pp. 801-807, 2010.
140. P.M. Herst, K.W. R. Broadley, J.L. Harper, and M. J. McConnell, "Pharmacological concentrations of ascorbate radiosensitize glioblastoma multiforme primary cells by increasing oxidative DNA damage and inhibiting G2/M arrest," Free Radical Biology and Medicine, vol. 52, no. 8, pp. 1486-1493, 2012.
141. M. Menon, C. Maramag, R. K. Malhotra, and L. Seethalakshmi, "Effect of vitamin C on androgen independent prostate cancer cells (PC3 and Mat-Ly-Lu) in vitro: involvement of reactive oxygen species-effect on cell number, viability and DNA synthesis," Cancer Biochemistry Biophysics, vol. 16, no. 1-2, pp. 17-30, 1998.
142. M. Venugopal, J. M. Jamison, J. Gilloteaux et al., "Synergistic antitumour activity of vitamins C and K3 against human prostate carcinoma cell lines," Cell Biology International, vol. 20, no. 12, pp. 787-797, 1996.
143. M. Venugopal, J. M. Jamison, J. Gilloteaux et al., "Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines," Life Sciences, vol. 59, no. 17, pp. 1389-1400, 1996.
144. M. Tomasetti, E. Strafella, S. Staffolani, L. Santarelli, J. Neuzil, and R. Guerrieri, "α-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate," British Journal of Cancer, vol. 102, no. 8, pp. 1224-1234, 2010.
145. 3 combination," Journal of Histochemistry and Cytochemistry, vol. 49, no. 1, pp. 109-119, 2001.
146. J. M. Jamison, J. Gilloteaux, H. S. Taper, and J. L. Summers, "Evaluation of the in vitro and in vivo antitumor activities of vitamin C and K-3 combinations against human prostate cancer," Journal of Nutrition, vol. 131, supplement 1, pp. 158S- 160S, 2001.
147. E. Maioli, C. Torricelli, and G. Valacchi, "Rottlerin and cancer: novel evidence and mechanisms," The Scientific World Journal, vol. 2012, Article ID350826, 11 pages, 2012.
148. P. Makhov, K. Golovine, D. Canter et al., "Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity," Prostate, vol. 72, no. 6, pp. 661-667, 2012.
149. A. Samykutty, A. V. Shetty, G. Dakshinamoorthy et al., "Piperine, a bioactive component of pepper spice exerts therapeutic effects on androgen dependent and androgen independent prostate cancer cells," PLoSONE, vol. 8, no. 6, Article IDe65889, 2013.
150. S. Ginzburg, K. V. Golovine, P. B. Makhov, R. G. Uzzo, A. Kutikov, and V. M. Kolenko, "Piperlongumine inhibits NF- κB activity and attenuates aggressive growth characteristics of prostate cancer cells," The Prostate, vol. 74, no. 2, pp. 177-186, 2014.
151. T. Rabi and S. Gupta, "Dietary terpenoids and prostate cancer chemoprevention," Frontiers in Bioscience, vol. 13, no. 9, pp. 3457-3469, 2008.
152. Y. Zhang, C. Kong, Y. Zeng et al., "Ursolic acid induces PC-3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro," Molecular Carcinogenesis, vol. 49, no. 4, pp. 374-385, 2010.
153. M. K. Shanmugam, T. H. Ong, A. P. Kumar et al., "Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating proinflammatory pathways," PLoS ONE, vol. 7, no. 3, Article ID e32476, 2012.
154. S. Leng, Y. Hao, D. Du et al., "Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy," International Journal of Cancer, vol. 133, no. 12, pp. 2781-2790, 2013.
155. C. Zhao, S. Yin, Y. Dong et al., "Autophagy-dependent EIF2AK3 activation compromises ursolic acid-induced apoptosis through upregulation of MCL1 in MCF-7 human breast cancer cells," Autophagy, vol. 9, no. 2, pp. 196-207, 2013.
156. C. P. R. Xavier, C. F. Lima, D. F. N. Pedro, J. M. Wilson, K. Kristiansen, and C. Pereira-Wilson, "Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells," Journal of Nutritional Biochemistry, vol. 24, no. 4, pp. 706-712, 2013.
157. L. Niu, J. Deng, F. Zhu et al., "Anti-inflammatory effect of Marchantin M contributes to sensitization of prostate cancer cells to docetaxel," Cancer Letters, vol. 348, no. 1-2, pp. 126-134, 2014.
158. A.-H. Xu, Z.-M. Hu, J.-B. Qu et al., "Cyclic bisbibenzyls induce growth arrest and apoptosis of human prostate cancer PC3 cells," Acta Pharmacologica Sinica, vol. 31, no. 5, pp. 609-615, 2010.
159. P. Patakova, "Monascus secondary metabolites: production and biological activity," Journal of Industrial Microbiology and Biotechnology, vol. 40, no. 2, pp. 169-181, 2013.
160. W.-H. Hsu and T.-M. Pan, "Monascus purpureus-fermented products and oral cancer: a review," Applied Microbiology and Biotechnology, vol. 93, no. 5, pp. 1831-1842, 2012.